TP53 and central nervous system cancer: Expression of H3.3K27M together with TP53 inactivation and PDGFRA amplification results in glioma-like tumors when targeted to mouse postnatal neural progenitor cells (NPCs) [68,69] or xenografted human embryonic stem cell (hESC)-derived NPCs [70].